Irgasan, diphenyl ether derivative, is used as a component of cefsulodin-irgasan-novobiocin selection medium for Yersinia, a human pathogen that may contaminate animal-source food products. Because of its low antigenicity, irgasan is also a component of many antibacterial consumer products. Irgasan is a broad spectrum antimicrobial agent. It is an inhibitor of the enoyl-ACP (acyl-carrier protein) reductase component of type II fatty acid synthase (FAS-II) in bacteria and Plasmodium. It also inhibits mammalian fatty acid synthase (FASN), and may have anticarcinogenic activity. Synonyms: 5-Chloro-2-(2,4-dichloro-3,5,6-d3-phenoxy)phenol, 2,4,4-Trichloro-2-hydroxydiphenyl ether CAS No: 3380-34-5 Molecular Formula: C12H7Cl3O2 Molecular Weight: 289.54 Appearance: Supplied as a colorless to white powder. Purity (HPLC): 97% Infrared Spectrum: Conforms to Structure Identification A, B: To pass test Melting Point: 56-58C 4-Mono chlorophenols: 0.5ug 2,4-dichlorophenol: 0.1ug 2,8-dichlorodibenzofuran: 0.25ppm 2,4,8-trichlorodibenzofuran: 0.5ppm 1,3,7-trichlorodibenzo-p-dioxin: 0.25ppm 2,8-dichlorodibenzo-p-dioxin: 0.5ppm 2,3,7,8-tetrachlorodibenzo-p-dioxin: 0.001ug/kg 2,3,7,8-tetrachlorodibenzofuran: 0.001ug/kg Related Substances: Individual Impurity: 0.1% Total Impurities: 0.5% Water (KF): 0.1% Solubility: Clear solution (1.4g in10 ml acetone Storage: RT Meets or exceeds USP specifications
Molekulargewicht:
289.54
Reinheit:
97% (HPLC)
Formulierung:
Supplied as a colorless to white powder.
CAS Nummer:
[3380-34-5]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten